Arcutis Biotherapeutics, Inc.
ARQT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787306
In the last 90 days, Arcutis Biotherapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 272 institutions reported holding it in 13F filings for Q2 2026, worth $3.45B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Arcutis Biotherapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- +1 vs. Q2 2021
- Shares held
- 45.7M
- +222.7K (+0.5%) vs. Q2 2021
- Total value
- $1.09B
- −$149.4M (−12.0%) vs. Q2 2021
- New holders
- 12
- 28 more added
- Sold out
- 11
- 33 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARQT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 272 | $3.45B |
| Q1 2026 | 270 | $3.12B |
| Q4 2025 | 283 | $3.75B |
| Q3 2025 | 239 | $2.37B |
| Q2 2025 | 230 | $1.78B |
| Q1 2025 | 241 | $1.97B |
| Q4 2024 | 208 | $1.79B |
| Q3 2024 | 188 | $1.20B |
| Q2 2024 | 186 | $1.18B |
| Q1 2024 | 168 | $1.24B |
| Q4 2023 | 133 | $327.1M |
| Q3 2023 | 134 | $356.7M |
| Q2 2023 | 136 | $684.0M |
| Q1 2023 | 144 | $787.6M |
| Q4 2022 | 141 | $979.6M |
| Q3 2022 | 139 | $1.13B |
| Q2 2022 | 115 | $1.05B |
| Q1 2022 | 106 | $929.8M |
| Q4 2021 | 93 | $961.8M |
| Q3 2021 | 103 | $1.09B |
| Q2 2021 | 102 | $1.24B |
| Q1 2021 | 94 | $1.35B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Arcutis Biotherapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 6,073,850 | $145.1M | 1.61% | 00.0% | Unchanged |
| FMR LLC | 7,536,265 | $180.0M | 0.01% | +5,525+0.1% | Added |
| Frazier Management LLC | 8,434,232 | $201.5M | 16.12% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −73,686−100.0% | Sold out |
| Greenspring Associates, LLC | 0 | $0 | 0.00% | −35,210−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −15,138−100.0% | Sold out |
| ACT Capital Management, LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −8,960−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −7,976−100.0% | Sold out |
| Ballentine Partners, LLC | 0 | $0 | 0.00% | −7,377−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −596−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −260−100.0% | Sold out |
| American Portfolios Advisors | 0 | $0 | 0.00% | −175−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −64−100.0% | Sold out |